Srs Capital Advisors, Inc. Durect Corp Transaction History

Srs Capital Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.9 - $1.31 $3,600 - $5,240	-4,000 Reduced 10.73%	33,295 $33,000
Q2 2021 Aug 02, 2021	BUY	$1.6 - $2.02 $4,904 - $6,191	3,065 Added 8.95%	37,295 $61,000
Q1 2020 May 13, 2020	BUY	$0.97 - $2.85 $1,455 - $4,275	1,500 Added 4.58%	34,230 $53,000
Q4 2019 Feb 07, 2020	BUY	$1.69 - $3.8 $4,225 - $9,500	2,500 Added 8.27%	32,730 $124,000
Q3 2017 Nov 15, 2017	BUY	$1.55 - $1.82 $46,856 - $55,018	30,230	30,230 $53,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $194M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.